Mediators of the Resolution of the Inflammatory Response
Tài liệu tham khảo
Medzhitov, 2010, Inflammation 2010: new adventures of an old flame, Cell, 140, 771, 10.1016/j.cell.2010.03.006
Serhan, 2007, Resolution of inflammation: state of the art, definitions and terms, FASEB J., 21, 325, 10.1096/fj.06-7227rev
Fullerton, 2016, Resolution of inflammation: a new therapeutic frontier, Nat. Rev. Drug Discov., 15, 551, 10.1038/nrd.2016.39
Perretti, 2015, Resolution pharmacology: opportunities for therapeutic innovation in inflammation, Trends Pharmacol. Sci., 36, 737, 10.1016/j.tips.2015.07.007
Chiang, 2012, Infection regulates pro-resolving mediators that lower antibiotic requirements, Nature, 484, 524, 10.1038/nature11042
Karin, 2004, The IKK NF-kappa B system: a treasure trove for drug development, Nat. Rev. Drug Discov., 3, 17, 10.1038/nrd1279
Newson, 2014, Resolution of acute inflammation bridges the gap between innate and adaptive immunity, Blood, 124, 1748, 10.1182/blood-2014-03-562710
Newson, 2017, Inflammatory resolution triggers a prolonged phase of immune suppression through COX-1/mPGES-1-derived prostaglandin E2, Cell Rep., 20, 3162, 10.1016/j.celrep.2017.08.098
Hashiguchi, 2013, Identification and characterization of a novel kaempferol sulfotransferase from Arabidopsis thaliana, Biochem. Biophys. Res. Commun., 434, 829, 10.1016/j.bbrc.2013.04.022
Sauer, 2006, Interferons limit inflammatory responses by induction of tristetraprolin, Blood, 107, 4790, 10.1182/blood-2005-07-3058
Zhu, 2018, MicroRNA-21 inhibits lipopolysaccharide-induced acute lung injury by targeting nuclear factor-kappaB, Exp. Ther. Med., 16, 4616
Taganov, 2006, NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses, Proc. Natl. Acad. Sci. U. S. A., 103, 12481, 10.1073/pnas.0605298103
Linker, 2005, Involvement of KSRP in the post-transcriptional regulation of human iNOS expression-complex interplay of KSRP with TTP and HuR, Nucleic Acids Res., 33, 4813, 10.1093/nar/gki797
Carballo, 1998, Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin, Science, 281, 1001, 10.1126/science.281.5379.1001
Jamieson, 2005, The chemokine receptor D6 limits the inflammatory response in vivo, Nat. Immunol., 6, 403, 10.1038/ni1182
Gresnigt, 2012, Neutrophil-mediated inhibition of proinflammatory cytokine responses, J. Immunol., 189, 4806, 10.4049/jimmunol.1103551
Hind, 2018, Neutrophil reverse migration and a chemokinetic resolution, Dev. Cell, 47, 404, 10.1016/j.devcel.2018.11.004
Huang, 2015, Damage-associated molecular pattern-activated neutrophil extracellular trap exacerbates sterile inflammatory liver injury, Hepatology, 62, 600, 10.1002/hep.27841
Knight, 2013, Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus, J. Clin. Invest., 123, 2981, 10.1172/JCI67390
Warnatsch, 2015, Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis, Science, 349, 316, 10.1126/science.aaa8064
Wong, 2015, Diabetes primes neutrophils to undergo NETosis, which impairs wound healing, Nat. Med., 21, 815, 10.1038/nm.3887
Shao, 2011, Disturbances of apoptotic cell clearance in systemic lupus erythematosus, Arthritis Res. Ther., 13, 202, 10.1186/ar3206
Fadok, 1998, Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF, J. Clin. Invest., 101, 890, 10.1172/JCI1112
Huynh, 2002, Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-β1 secretion and the resolution of inflammation, J. Clin. Invest., 109, 41, 10.1172/JCI0211638
Byrne, 2002, Lipopolysaccharide induces rapid production of IL-10 by monocytes in the presence of apoptotic neutrophils, J. Immunol., 168, 1968, 10.4049/jimmunol.168.4.1968
Wynn, 2016, Macrophages in tissue repair, regeneration, and fibrosis, Immunity, 44, 450, 10.1016/j.immuni.2016.02.015
Saclier, 2013, Differentially activated macrophages orchestrate myogenic precursor cell fate during human skeletal muscle regeneration, Stem Cell, 31, 384, 10.1002/stem.1288
Eming, 2017, Inflammation and metabolism in tissue repair and regeneration, Science, 356, 1026, 10.1126/science.aam7928
Serhan, 2015, Lipid mediators in the resolution of inflammation, Cold Spring Harb. Perspect. Biol., 7, 10.1101/cshperspect.a016311
Wallace, 2015, Gaseous mediators in resolution of inflammation, Semin. Immunol., 27, 227, 10.1016/j.smim.2015.05.004
Hasko, 2013, Regulation of inflammation by adenosine, Front. Immunol., 4, 85, 10.3389/fimmu.2013.00085
Mirakaj, 2014, Vagus nerve controls resolution and pro-resolving mediators of inflammation, J. Exp. Med., 211, 1037, 10.1084/jem.20132103
Montero-Melendez, 2015, ACTH: the forgotten therapy, Semin. Immunol., 27, 216, 10.1016/j.smim.2015.02.003
Sugimoto, 2016, Resolution of inflammation: what controls its onset?, Front. Immunol., 7, 160, 10.3389/fimmu.2016.00160
McArthur, 2015, Definition of a novel pathway centered on lysophosphatidic acid to recruit monocytes during the resolution phase of tissue inflammation, J. Immunol., 195, 1139, 10.4049/jimmunol.1500733
Maderna, 2010, FPR2/ALX receptor expression and internalization are critical for lipoxin A4 and annexin-derived peptide-stimulated phagocytosis, FASEB J., 24, 4240, 10.1096/fj.10-159913
Scannell, 2007, Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages, J. Immunol., 178, 4595, 10.4049/jimmunol.178.7.4595
Solito, 2003, A novel calcium-dependent proapoptotic effect of annexin 1 on human neutrophils, FASEB J., 17, 1544, 10.1096/fj.02-0941fje
Vago, 2012, Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis, J. Leukoc. Biol., 92, 249, 10.1189/jlb.0112008
Patruno, 2018, Ligand bias and its association with pro-resolving actions of melanocortin drugs, Front. Pharmacol., 9, 919, 10.3389/fphar.2018.00919
Montero-Melendez, 2011, The melanocortin agonist AP214 exerts anti-inflammatory and proresolving properties, Am. J. Pathol., 179, 259, 10.1016/j.ajpath.2011.03.042
Magalhaes, 2018, Angiotensin-(1-7) promotes resolution of eosinophilic inflammation in an experimental model of asthma, Front. Immunol., 9, 58, 10.3389/fimmu.2018.00058
Barroso, 2017, Angiotensin-(1-7) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice, Front. Immunol., 8, 1596, 10.3389/fimmu.2017.01596
Simoes e Silva, 2013, ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis, Br. J. Pharmacol., 169, 477, 10.1111/bph.12159
Barroso, 2012, Renoprotective effects of AVE0991, a nonpeptide Mas receptor agonist, in experimental acute renal injury, Int. J. Hypertens., 2012, 10.1155/2012/808726
da Silveira, 2010, Anti-inflammatory effects of the activation of the angiotensin-(1-7) receptor, MAS, in experimental models of arthritis, J. Immunol., 185, 5569, 10.4049/jimmunol.1000314
Sugimoto, 2017, Plasmin and plasminogen induce macrophage reprogramming and regulate key steps of inflammation resolution via annexin A1, Blood, 129, 2896, 10.1182/blood-2016-09-742825
Rosenwald, 2012, Serum-derived plasminogen is activated by apoptotic cells and promotes their phagocytic clearance, J. Immunol., 189, 5722, 10.4049/jimmunol.1200922
Colas, 2014, Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue, Am. J. Physiol. Cell Physiol., 307, C39, 10.1152/ajpcell.00024.2014
Coombs, 2004, Effects of the geometry of the immunological synapse on the delivery of effector molecules, Biophys. J., 87, 2215, 10.1529/biophysj.104.045674
Bannenberg, 2005, Molecular circuits of resolution: formation and actions of resolvins and protectins, J. Immunol., 174, 4345, 10.4049/jimmunol.174.7.4345
Galvao, 2017, Annexin A1 promotes timely resolution of inflammation in murine gout, Eur. J. Immunol., 47, 585, 10.1002/eji.201646551
Lima, 2017, The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1, J. Biol. Chem., 292, 13758, 10.1074/jbc.M117.800391
Patel, 2015, Human experimental endotoxemia in modeling the pathophysiology, genomics, and therapeutics of innate immunity in complex cardiometabolic diseases, Arterioscler. Thromb. Vasc. Biol., 35, 525, 10.1161/ATVBAHA.114.304455
Morris, 2010, Dichotomy in duration and severity of acute inflammatory responses in humans arising from differentially expressed proresolution pathways, Proc. Natl. Acad. Sci. U. S. A., 107, 8842, 10.1073/pnas.1000373107
Flower, 1979, Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation, Nature, 278, 456, 10.1038/278456a0
Sugimoto, 2016, Annexin A1 and the resolution of inflammation: modulation of neutrophil recruitment, apoptosis, and clearance, J. Immunol. Res., 2016, 10.1155/2016/8239258
Sheikh, 2018, Annexin A1: uncovering the many talents of an old protein, Int. J. Mol. Sci., 19, E1045, 10.3390/ijms19041045
Dalli, 2013, Proresolving and tissue-protective actions of annexin A1-based cleavage-resistant peptides are mediated by formyl peptide receptor 2/lipoxin A4 receptor, J. Immunol., 190, 6478, 10.4049/jimmunol.1203000
Kusters, 2015, Pharmacological treatment with annexin A1 reduces atherosclerotic plaque burden in LDLR-/- mice on Western type diet, PLoS One, 10, 10.1371/journal.pone.0130484
Leoni, 2015, Annexin A1-containing extracellular vesicles and polymeric nanoparticles promote epithelial wound repair, J. Clin. Invest., 125, 1215, 10.1172/JCI76693
Perretti, 2001, Involvement of the receptor for formylated peptides in the in vivo anti-migratory actions of annexin 1 and its mimetics, Am. J. Pathol., 158, 1969, 10.1016/S0002-9440(10)64667-6
Arur, 2003, Annexin I is an endogenous ligand that mediates apoptotic cell engulfment, Dev. Cell, 4, 587, 10.1016/S1534-5807(03)00090-X
Souza, 2007, The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice, J. Immunol., 179, 8533, 10.4049/jimmunol.179.12.8533
Vago, 2015, The role and effects of glucocorticoid-induced leucine zipper in the context of inflammation resolution, J. Immunol., 194, 4940, 10.4049/jimmunol.1401722
Damazo, 2006, Spatial and temporal profiles for anti-inflammatory gene expression in leukocytes during a resolving model of peritonitis, J. Immunol., 176, 4410, 10.4049/jimmunol.176.7.4410
Damazo, 2011, Endogenous annexin A1 counter-regulates bleomycin-induced lung fibrosis, BMC Immunol., 12, 59, 10.1186/1471-2172-12-59
Yazid, 2015, Annexin-A1 restricts Th17 cells and attenuates the severity of autoimmune disease, J. Autoimmun., 58, 1, 10.1016/j.jaut.2014.12.004
Cristante, 2013, Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications, Proc. Natl. Acad. Sci. U. S. A., 110, 832, 10.1073/pnas.1209362110
Lee, 2018, Annexin A1 in plasma from patients with bronchial asthma: its association with lung function, BMC Pulm. Med., 18, 1, 10.1186/s12890-017-0557-5
Vong, 2012, Up-regulation of Annexin-A1 and lipoxin A(4) in individuals with ulcerative colitis may promote mucosal homeostasis, PLoS One, 7, 10.1371/journal.pone.0039244
Sena, 2013, Dysregulation of anti-inflammatory annexin A1 expression in progressive Crohns disease, PLoS One, 8, 10.1371/journal.pone.0076969
Khajah, 2017, Anti-inflammatory action of angiotensin 1-7 in experimental colitis may be mediated through modulation of serum cytokines/chemokines and immune cell functions, Dev. Comp. Immunol., 74, 200, 10.1016/j.dci.2017.05.005
Hammer, 2016, Role of the receptor Mas in macrophage-mediated inflammation in vivo, Proc. Natl. Acad. Sci. U. S. A., 113, 14109, 10.1073/pnas.1612668113
Thatcher, 2012, Deficiency of ACE2 in bone-marrow-derived cells increases expression of TNF-alpha in adipose stromal cells and augments glucose intolerance in obese C57BL/6 mice, Int. J. Hypertens., 2012, 10.1155/2012/762094
Magalhaes, 2015, Angiotensin-(1-7) attenuates airway remodelling and hyperresponsiveness in a model of chronic allergic lung inflammation, Br. J. Pharmacol., 172, 2330, 10.1111/bph.13057
Marques, 2011, An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats, Hypertension, 57, 477, 10.1161/HYPERTENSIONAHA.110.167346
Motwani, 2018, Pro-resolving mediators promote resolution in a human skin model of UV-killed Escherichia coli-driven acute inflammation, JCI Insight, 3, 10.1172/jci.insight.94463
Dalli, 2017, Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes, Crit. Care Med., 45, 58, 10.1097/CCM.0000000000002014
Dalli, 2018, Identification and structure elucidation of the pro-resolving mediators provides novel leads for resolution pharmacology, Br. J. Pharmacol.
Chiang, 2017, Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors, Mol. Aspects Med., 58, 114, 10.1016/j.mam.2017.03.005
Fredman, 2016, An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques, Nat. Commun., 7, 12859, 10.1038/ncomms12859
Norling, 2016, Proresolving and cartilage-protective actions of resolvin D1 in inflammatory arthritis, JCI Insight, 1, 10.1172/jci.insight.85922
Jones, 2012, Microfluidic chambers for monitoring leukocyte trafficking and humanized nano-proresolving medicines interactions, Proc. Natl. Acad. Sci. U. S. A., 109, 20560, 10.1073/pnas.1210269109
Barden, 2016, Specialised pro-resolving mediators of inflammation in inflammatory arthritis, Prostaglandins Leukot. Essent. Fatty Acids, 107, 24, 10.1016/j.plefa.2016.03.004
Thul, 2017, Low salivary resolvin D1 to leukotriene B4 ratio predicts carotid intima media thickness: a novel biomarker of non-resolving vascular inflammation, Eur. J. Prev. Cardiol., 24, 903, 10.1177/2047487317694464
Dufton, 2010, Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation, J. Immunol., 184, 2611, 10.4049/jimmunol.0903526
Hellmann, 2018, Biosynthesis of D-series resolvins in skin provides insights into their role in tissue repair, J. Invest. Dermatol., 138, 2051, 10.1016/j.jid.2018.03.1498
Devchand, 2003, Human ALX receptor regulates neutrophil recruitment in transgenic mice: roles in inflammation and host defense, FASEB J., 17, 652, 10.1096/fj.02-0770com
He, 2017, The formyl peptide receptors: diversity of ligands and mechanism for recognition, Molecules, 22, E455, 10.3390/molecules22030455
Krishnamoorthy, 2010, Resolvin D1 binds human phagocytes with evidence for proresolving receptors, Proc. Natl. Acad. Sci. U. S. A., 107, 1660, 10.1073/pnas.0907342107
Chiang, 2015, Identification of resolvin D2 receptor mediating resolution of infections and organ protection, J. Exp. Med., 212, 1203, 10.1084/jem.20150225
Arita, 2005, Stereochemical assignment, antiinflammatory properties, and receptor for the omega-3 lipid mediator resolvin E1, J. Exp. Med., 201, 713, 10.1084/jem.20042031
Santos, 2003, Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas, Proc. Natl. Acad. Sci. U. S. A., 100, 8258, 10.1073/pnas.1432869100
Bystrom, 2008, Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP, Blood, 112, 4117, 10.1182/blood-2007-12-129767
Sousa, 2009, Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K/Akt and NF-kappaB, Biochem. Pharmacol., 78, 396, 10.1016/j.bcp.2009.04.030
Sousa, 2010, PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K/Akt-dependent and NF-kappaB-independent manner, J. Leukoc. Biol., 87, 895, 10.1189/jlb.0809540
Lee, 2013, Resolvin D1-mediated NOX2 inactivation rescues macrophages undertaking efferocytosis from oxidative stress-induced apoptosis, Biochem. Pharmacol., 86, 759, 10.1016/j.bcp.2013.07.002
Raker, 2016, The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases, Front. Immunol., 7, 123, 10.3389/fimmu.2016.00123
Park, 2011, Resolvin D2 is a potent endogenous inhibitor for transient receptor potential subtype V1/A1, inflammatory pain, and spinal cord synaptic plasticity in mice: distinct roles of resolvin D1, D2, and E1, J. Neurosci., 31, 18433, 10.1523/JNEUROSCI.4192-11.2011
Chiurchiu, 2016, Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses, Sci. Transl. Med., 8, 353ra111, 10.1126/scitranslmed.aaf7483
Pope, 2016, D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization, FASEB J., 30, 4192, 10.1096/fj.201600144RR
McCartney-Francis, 2014, Aberrant host defense against Leishmania major in the absence of SLPI, J. Leukoc. Biol., 96, 917, 10.1189/jlb.4A0612-295RR
Vago, 2016, Proresolving actions of synthetic and natural protease inhibitors are mediated by annexin A1, J. Immunol., 196, 1922, 10.4049/jimmunol.1500886
Py, 2009, The phospholipid scramblases 1 and 4 are cellular receptors for the secretory leukocyte protease inhibitor and interact with CD4 at the plasma membrane, PLoS One, 4, 10.1371/annotation/657cd713-aaac-4ebb-80ad-3ec8dfb12b42
Williams, 2006, SLPI and elafin: one glove, many fingers, Clin. Sci. (Lond.), 110, 21, 10.1042/CS20050115
Wallace, 2009, Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats, Gastroenterology, 137, 569, 10.1053/j.gastro.2009.04.012
Gemici, 2015, H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential, Nitric Oxide, 46, 25, 10.1016/j.niox.2014.11.010
Serhan, 2018, New pro-resolving n-3 mediators bridge resolution of infectious inflammation to tissue regeneration, Mol. Aspects Med., 64, 1, 10.1016/j.mam.2017.08.002
Tang, 2018, Maresins: specialized proresolving lipid mediators and their potential role in inflammatory-related diseases, Mediators Inflamm., 2018, 10.1155/2018/2380319
Ramon, 2016, The protectin PCTR1 is produced by human M2 macrophages and enhances resolution of infectious inflammation, Am. J. Pathol., 186, 962, 10.1016/j.ajpath.2015.12.012
de la Rosa, 2018, Identification and complete stereochemical assignments of the new resolvin conjugates in tissue regeneration in human tissues that stimulate proresolving phagocyte functions and tissue regeneration, Am. J. Pathol., 188, 950, 10.1016/j.ajpath.2018.01.004
Sulniute, 2016, Plasminogen is a critical regulator of cutaneous wound healing, Thromb. Haemost., 115, 1001, 10.1160/TH15-08-0653
Carmo, 2014, Plasmin induces in vivo monocyte recruitment through protease-activated receptor-1-, MEK/ERK-, and CCR2-mediated signaling, J. Immunol., 193, 3654, 10.4049/jimmunol.1400334
Ronchetti, 2015, GILZ as a mediator of the anti-inflammatory effects of glucocorticoids, Front. Endocrinol. (Lausanne), 6, 170, 10.3389/fendo.2015.00170
Kourtzelis, 2019, DEL-1 promotes macrophage efferocytosis and clearance of inflammation, Nat. Immunol., 20, 40, 10.1038/s41590-018-0249-1
Campbell, 2011, Antimicrobial aspects of inflammatory resolution in the mucosa: a role for proresolving mediators, J. Immunol., 187, 3475, 10.4049/jimmunol.1100150
Dufton, 2012, Hydrogen sulfide and resolution of acute inflammation: a comparative study utilizing a novel fluorescent probe, Sci. Rep., 2, 499, 10.1038/srep00499